Introduction The landscape of modern oncology is currently experiencing a profound paradigm shift, largely driven by the rapid evolution of cellular immunotherapy. Traditional treatment modalities, while historically foundational, frequently lack the precision required to eradicate complex malignancies without exacting a heavy toll on healthy tissues. In response to these clinical limitations, researchers and clinicians are […]